Table 1.
Characteristics of primary pancreatic cancer
| Primary operation | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No | Age | Gender (M/F) | Location | Operation | Differentiation | Tumor size(mm) | UICC | Stage | Pancreatic duct margin | Preoperative CA19-9 levels(U/ml) | Postoperative adjuvant chemotherapy |
| 1 | 67 | M | Head | PD | Moderately | 25 | T3N1M0 | IIB | (−) | Not described | (−) |
| 2 | 66 | F | Body | DP | Moderately | 30 | T2N0M0 | IB | (−) | 56 | (−) |
| 3 | 54 | M | Body | DP | Moderately | 17 | T3N0M0 | IIA | (−) | Not described | (−) |
| 4 | 53 | M | Head | PPPD+PV | Well | 15 | T3N0M0 | IIA | (−) | 1 | (−) |
| 5 | 63 | M | Head | PPPD | Moderately | 13 | T1N0M0 | IA | (−) | Not described | (−) |
| 6 | 72 | M | Head | PD+PV | Moderately | 30 | T3N0M0 | IIA | dysplasia | Not described | (−) |
| 7 | 57 | M | Head | PD | Moderately | 15 | T3N1M0 | IIB | (−) | 19 | (−) |
| 8 | 60 | M | Body | DP | Well | 33 | T3N0M0 | IIA | (−) | 179 | GEM |
| 9 | 56 | M | Head | PPPD | Moderately | 45 | T3N1M0 | IIB | (+) | 1910 | S-1 |
| 10 | 59 | F | Head | PPPD+PV | moderately | 37 | T3N1M1 | IV | (−) | 420 | GEM |
| 11 | 55 | M | Head | PPPD+PV | Moderately | 45 | T3N0M0 | IIA | (+) | 784 | GEM |
| 12 | 58 | F | Body | DP | Moderately | 30 | T3N0M0 | IIA | (+) | Not described | (−) |
| 13 | 82 | M | Body | DP+PV | Moderately | 20 | T3N0M0 | IIA | PanIN-1B | 8 | (−) |
| 14 | 69 | M | Body | DP | Moderately | 15 | T3N0M0 | IIA | (−) | 113 | (−) |
| 15 | 59 | F | Head | DPPHR | Poorly | 15 | T3N0M0 | IIA | (−) | 64 | (−) |
| 16 | 55 | F | Body | DP+Ace | Moderately | 80 | T3N1M1 | IV | (−) | 362 | immunotherapy |
| 17 | 62 | M | Head | PPPD+PV | Moderately | 30 | T3N1M0 | IIB | (−) | 138 | GEM |
| 18 | 65 | F | Body | DP | Moderately | 15 | T1N0M0 | IA | (−) | 15 | (−) |
| 19 | 70 | F | Body | Dorsal pancreas resection+DP | Moderately | 13 | T2N0M0 | IB | (−) | 14 | GEM |
| 20 | 57 | M | Head | PPPD+PV | Moderately | 15 | T3N1M0 | IIB | (−) | 19 | GEM |
| 21 | 48 | M | Body | DP | Papillary | 25 | T3N0M0 | IIA | (−) | 24 | GEM+immunotherpy |
| 22 | 82 | F | Body | DP | Moderately | 15 | T3N1M0 | IIB | (−) | 9 | GEM+immunotherpy |
| 23 | 63 | F | Head | PPPD | Well | 20 | T3N1M0 | IIB | (−) | 84 | S-1 |
PD pancreaticoduodenectomy, DP distal pancreatectomy, PPPD pylorus preserving PD, PV portal vein resection and reconstruction, DPPHR duodenum preserving pancreas head resection, y year, m month, IOR intraoperative radiation, BSC best supportive care, SSPPD subtotal stomach preserving pancreaticoduodenectomy, IPMC intraductal papillary mucinous carcinoma GEM gemcitabine